Determining the Longitudinal Serologic Response to COVID-19 Vaccination in the Chronic Kidney Disease Population: A Clinical Research Protocol.
Yau K, Enilama O, Levin A, Romney MG, Singer J, Blake P, Perl J, Leis JA, Kozak R, Tsui H, Bolotin S, Tran V, Chan CT, Tam P, Dhruve M, Kandel C, Estrada-Codecido J, Brown T, Siwakoti A, Abe KT, Hu Q, Colwill K, Gingras AC, Oliver MJ, Hladunewich MA.
Yau K, et al.
Can J Kidney Health Dis. 2023 Mar 20;10:20543581231160511. doi: 10.1177/20543581231160511. eCollection 2023.
Can J Kidney Health Dis. 2023.
PMID: 36950028
Free PMC article.
SETTING: Participating outpatient kidney programs within Ontario and British Columbia. PATIENTS: Up to 2500 participants with CKD G3b-5D receiving COVID-19 vaccination, including participants receiving dialysis and kidney transplant recipients (CKD G1T-5T). ...
SETTING: Participating outpatient kidney programs within Ontario and British Columbia. PATIENTS: Up to 2500 participants with CKD G3b-5D …